Ingevity (NGVT) Expected to Announce Earnings on Monday

Ingevity (NYSE:NGVT) is projected to release its Q2 2025 earnings data after the market closes on Monday, August 4th. Analysts expect Ingevity to post earnings of $1.02 per share and revenue of $378.70 million for the quarter.

Ingevity (NYSE:NGVT) last posted its earnings results on Wednesday, May 7th. The company reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.25. Ingevity had a positive return on equity of 63.76% and a negative net margin of 26.20%. The company had revenue of $284.00 million for the quarter, compared to analyst estimates of $299.13 million. During the same quarter last year, the company earned $0.47 earnings per share. The company’s revenue for the quarter was down 16.5% on a year-over-year basis. On average, analysts expect Ingevity to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Ingevity Stock Down 3.3%

NGVT stock opened at $40.43 on Friday. Ingevity has a twelve month low of $28.49 and a twelve month high of $51.67. The company has a quick ratio of 1.08, a current ratio of 2.00 and a debt-to-equity ratio of 5.68. The stock’s 50 day moving average is $43.91 and its 200-day moving average is $42.05. The firm has a market capitalization of $1.47 billion, a PE ratio of -4.15 and a beta of 1.36.

Institutional Trading of Ingevity

A number of hedge funds have recently bought and sold shares of the business. Empowered Funds LLC increased its position in Ingevity by 12.9% in the first quarter. Empowered Funds LLC now owns 5,181 shares of the company’s stock worth $205,000 after buying an additional 594 shares during the last quarter. AQR Capital Management LLC increased its position in Ingevity by 10.9% in the first quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after buying an additional 1,323 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Ingevity by 5.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 21,790 shares of the company’s stock worth $863,000 after buying an additional 1,080 shares during the last quarter. Jane Street Group LLC increased its position in Ingevity by 306.1% in the first quarter. Jane Street Group LLC now owns 88,883 shares of the company’s stock worth $3,519,000 after buying an additional 66,995 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Ingevity by 311.8% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 600,380 shares of the company’s stock worth $23,769,000 after buying an additional 454,579 shares during the last quarter. 91.59% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on NGVT shares. Wall Street Zen lowered Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday, July 26th. Wells Fargo & Company lifted their price target on Ingevity from $38.00 to $48.00 and gave the stock an “equal weight” rating in a report on Monday, July 14th.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.